Harry L.A. Janssen

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

Pietro Lampertico, Kosh Agarwal, Thomas Berg et al. · Journal of Hepatology · 2017 · 5.4K citations

Pharmacy, Infectious Diseases, Internal Medicine +16

Treatment of HCV Infection by Targeting MicroRNA

Harry L.A. Janssen, Hendrik W. Reesink, Eric Lawitz et al. · New England Journal of Medicine · 2013 · 2.2K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis

Bart J. Veldt, Jordan J. Feld, Heiner Wedemeyer et al. · JAMA · 2012 · 1.5K citations · Full text

Medicine, Infectious Diseases, Internal Medicine +17

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

Harry L.A. Janssen, Monika van Zonneveld, Hakan Şentürk et al. · The Lancet · 2005 · 1.2K citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity

Ton Lisman, T.N. Bongers, Jelle Adelmeijer et al. · Hepatology · 2006 · 602 citations

Medicine, Hematology, Pathology +17